BioTherapeutics
Business Services · Virginia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1800 Kraft Dr SW Ste 200, Blacksburg, Vi...Phone Number
(540) 218-2262Website
www.biotherapeuticsinc.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About BioTherapeutics
BioTherapeutics Inc. (BTI) is a clinical-stage biotechnology company focused on precision medicine and health innovation, particularly in preventing and treating autoimmune and metabolic diseases. The company integrates nutritionals, therapeutics, and advanced informatics to develop interventions, including abscisic acid for glycemic control. BTI serves clients in the healthcare and pharmaceutical sectors, aiming to enhance drug development through innovative computational approaches. Founded in 2008, BTI leverages research from the NIMML Institute to address challenges in chronic inflammatory diseases.Explore more
BioTherapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioTherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at BioTherapeutics
Earning: See what the market has to say on BioTherapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once BioTherapeutics has new funding data
Product Launch: Get notified when BioTherapeutics launches new products
BioTherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if BioTherapeutics is spiking on competitors!
Check if BioTherapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if BioTherapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at BioTherapeutics
Find more new buyers
Compare Similar Companies to BioTherapeutics
Compare insights from companies similar to BioTherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BioTherapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BioTherapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BioTherapeutics.
BioTherapeutics financials insights
Gather financial insights about BioTherapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$64K
BioTherapeutics Tech Stack
A closer look at the technologies used by BioTherapeutics
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Funding
Project
Spending/Investment, Funding
Funding
Project
Spending/Investment, Funding
Funding
Project
Spending/Investment, Funding
Funding
Project
Award, Spending/Investment
BioTherapeutics News & Media
Inspire Biotherapeutics Raises Pre-Seed Funding
Inspire Biotherapeutics, a Toronto, Canada-based biotech company, raised an undisclosed amount in Pre-Seed funding. Inspire’s Business Founders – C3i Center Inc, Octane Medical Group of Companies, and Ontario Institute for Regenerative Medicine – are providing investment, corporate development, and commercialization strategy. The company intends to use the funds to accelerate its development efforts. Founded by […] The post Inspire Biotherapeutics Raises Pre-Seed Funding appeared first on FinSMEPerceive Biotherapeutics Closes $78M in Series B Funding
Perceive Biotherapeutics, a San Francisco, CA-based biotech company focused on technologies and therapeutics in ophthalmology, raised $78M in Series B funding. The round was led by Johnson & Johnson Innovation – JJDC, Inc.(JJDC), with participation from Deerfield Management, Braidwell LP, the Retinal Degeneration Fund, and Catalio Capital Management, LP. The company intends to use the […] The post Perceive Biotherapeutics Closes $78M in Series B Funding appeared first on FinSMEs.Endure Biotherapeutics, Inc. Announces Publication of Founder’s Seminal Work Regarding Colonizing Biotherapeutics
Zarrinpar Laboratory finds that engineering of native bacteria for therapeutic applications facilitates long term engraftment and treatment Zarrinpar Laboratory finds that engineering of native bacteria for therapeutic applications facilitates long term engraftment and treatment
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding BioTherapeutics
Sign Up For FreeTo access detailed company insights
BioTherapeutics Inc. (BTI) is a clinical-stage biotechnology company focused on precision medicine and health innovation, particularly in preventing and treating autoimmune and metabolic diseases. The company integrates nutritionals, therapeutics, and advanced informatics to develop interventions, including abscisic acid for glycemic control. BTI s... Read More
